Santosh D. Bhosale

Santosh D. Bhosale

Auto-generated profile, based on publicly available information

Santosh D. Bhosale

Department of Biochemistry and Molecular Biology University of Southern Denmark Odense Denmark

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2023 in Immunology Letters
Verified
Journal Article
Closed access
SASyed Bilal Ahmad Andrabi
Syed Bilal Ahmad Andrabi
KBKedar Batkulwar
Kedar Batkulwar
SBSantosh D. Bhosale
Santosh D. Bhosale
RMRobert Moulder
Robert Moulder
MKMeraj Hasan Khan
Meraj Hasan Khan
RLRiitta Lahesmaa
Riitta Lahesmaa

28 May 2026 in Annals of Neurology
Verified
Journal Article
Open access
SBSantosh D. Bhosale
Santosh D. Bhosale
ANArkadiusz Nawrocki
Arkadiusz Nawrocki
JKJohanne J. Korsbæk
Johanne J. Korsbæk
NHNadja S. Hansen
Nadja S. Hansen
FFFabian Foettinger
Fabian Foettinger
DBDagmar Beier
Dagmar Beier
Objectives: The pathophysiology of idiopathic intracranial hypertension (IIH) is poorly understood and disease‐specific biomarkers are lacking. We aimed to shed light on IIH pathophysiology and identify disease‐specific biomarkers. Methods: This prospective cross‐sectional cohort study included patients with new‐onset IIH and age‐, body mass index‐, and sex‐matched healthy controls from 2 tertiary Danish Headache Centers (discovery cohort). Liquid chromatography coupled to tandem mass spectrometry analysis was used to measure reproducible proteomic profiles for paired serum and cerebrospinal fluid (CSF) samples. Results were validated using 3 validation cohorts comprising patients with IIH (pwIIH), cerebral sinus venous thrombosis (pwCSVT), and normal pressure hydrocephalus (pwNPH). Results: We included 53 pwIIH and 35 controls. PwIIH presented with papilledema and increased median lumbar puncture opening pressure (interquartile range [IQR]) (38.0 [33–46] vs 19.0 [17.0–23.0] cmH 2 O; p < 0.001) compared to controls. Machine learning analysis identified 20 IIH‐predicting proteins for serum and CSF segregating pwIIH, but neither pwCSVT nor pwNPH, from controls with areas under the curve (AUC) of 0.84 and 0.92 (pwIIH, discovery cohort), 0.99 and 0.90 (pwIIH, validation cohort 1), 0.63 (plasma; pwCSVT), and 0.67 (CSF; pwNPH), respectively. Serum carbonic anhydrases (CA) 1 and 2 were upregulated and among the most IIH‐predicting proteins as were amyloid precursor protein (APP), S100P, and S100A12. Interpretation: We identified a panel of independently validated IIH‐specific candidate biomarkers. The serum candidate biomarkers pointed toward CA2 driven CSF hypersecretion in IIH providing a possible explanation for the therapeutic efficacy of CA inhibitors. The regulation of markers associated with neuronal impairment (APP, S100P/S100A12) confirmed the non‐benign character of IIH. ANN NEUROL 2026